Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury
Clinical trial NCT04475224 · UNKNOWN
Trial details
- NCT number
- NCT04475224
- Sponsor
- Kringle Pharma, Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-13
- Primary completion
- 2022-12-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.